These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 19079815

  • 1. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
    Brown E, Dunner DL, McElroy SL, Keck PE, Adams DH, Degenhardt E, Tohen M, Houston JP.
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):773-82. PubMed ID: 19079815
    [Abstract] [Full Text] [Related]

  • 2. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
    Brown EB, McElroy SL, Keck PE, Deldar A, Adams DH, Tohen M, Williamson DJ.
    J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
    [Abstract] [Full Text] [Related]

  • 3. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
    Keck PE, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.
    J Clin Psychiatry; 2005 May; 66(5):611-6. PubMed ID: 15889948
    [Abstract] [Full Text] [Related]

  • 4. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA, Perlis RH, Keck PE, Lin DY, Case MG, Williamson DJ, Tohen MF.
    J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
    [Abstract] [Full Text] [Related]

  • 5. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
    Perlis RH, Adams DH, Fijal B, Sutton VK, Farmen M, Breier A, Houston JP.
    J Clin Psychiatry; 2010 May; 71(5):599-605. PubMed ID: 20021991
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
    Detke HC, DelBello MP, Landry J, Usher RW.
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.
    Katagiri H, Tohen M, McDonnell DP, Fujikoshi S, Case M, Kanba S, Takahashi M, Gomez JC.
    BMC Psychiatry; 2013 May 14; 13():138. PubMed ID: 23672672
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct 14; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 9. Clinical relevance of depressive symptom improvement in bipolar I depressed patients.
    Williamson D, Brown E, Perlis RH, Ahl J, Baker RW, Tohen M.
    J Affect Disord; 2006 Jun 14; 92(2-3):261-6. PubMed ID: 16563521
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
    Corya SA, Williamson D, Sanger TM, Briggs SD, Case M, Tollefson G.
    Depress Anxiety; 2006 Jun 14; 23(6):364-72. PubMed ID: 16710853
    [Abstract] [Full Text] [Related]

  • 11. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
    Amsterdam JD, Shults J.
    J Affect Disord; 2005 Jul 14; 87(1):121-30. PubMed ID: 15923042
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study.
    Wang M, Tong JH, Huang DS, Zhu G, Liang GM, Du H.
    Psychopharmacology (Berl); 2014 Jul 14; 231(14):2811-8. PubMed ID: 24481570
    [Abstract] [Full Text] [Related]

  • 13. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.
    J Clin Psychiatry; 2001 Apr 14; 62(4):273-81. PubMed ID: 11379842
    [Abstract] [Full Text] [Related]

  • 14. Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial.
    Bobo WV, Epstein RA, Shelton RC.
    Hum Psychopharmacol; 2010 Jan 14; 25(1):30-6. PubMed ID: 20029794
    [Abstract] [Full Text] [Related]

  • 15. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
    Shi L, Namjoshi MA, Swindle R, Yu X, Risser R, Baker RW, Tohen M.
    Clin Ther; 2004 Jan 14; 26(1):125-34. PubMed ID: 14996525
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.
    Barbosa L, Berk M, Vorster M.
    J Clin Psychiatry; 2003 Apr 14; 64(4):403-7. PubMed ID: 12716240
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
    Tohen M, Case M, Trivedi MH, Thase ME, Burke SJ, Durell TM.
    J Clin Psychiatry; 2010 Apr 14; 71(4):451-62. PubMed ID: 20361905
    [Abstract] [Full Text] [Related]

  • 18. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.
    J Affect Disord; 2008 Jan 14; 105(1-3):101-8. PubMed ID: 17531327
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.
    Tamayo JM, Sutton VK, Mattei MA, Diaz B, Jamal HH, Vieta E, Zarate CA, Fumero I, Tohen M.
    J Clin Psychopharmacol; 2009 Aug 14; 29(4):358-61. PubMed ID: 19593175
    [Abstract] [Full Text] [Related]

  • 20. Effect of comorbid anxiety on treatment response in bipolar depression.
    Tohen M, Calabrese J, Vieta E, Bowden C, Gonzalez-Pinto A, Lin D, Xu W, Corya S.
    J Affect Disord; 2007 Dec 14; 104(1-3):137-46. PubMed ID: 17512607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.